These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16253319)

  • 41. Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys.
    Wakeford AGP; Sherwood AM; Prisinzano TE; Bergman J; Kohut SJ; Paronis CA
    Int J Neuropsychopharmacol; 2021 Aug; 24(8):656-665. PubMed ID: 33909067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.
    Oberlender R; Nichols DE
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1098-106. PubMed ID: 1979813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs.
    Dal Cason TA; Young R; Glennon RA
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1109-16. PubMed ID: 9408221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats.
    Herr KA; Baker LE
    Behav Pharmacol; 2020 Dec; 31(8):776-786. PubMed ID: 32960851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone.
    Berquist MD; Thompson NA; Baker LE
    Psychopharmacology (Berl); 2017 Nov; 234(21):3271-3278. PubMed ID: 28815279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 3-lever discrimination procedure reveals differences in the subjective effects of low and high doses of MDMA.
    Harper DN; Langen AL; Schenk S
    Pharmacol Biochem Behav; 2014 Jan; 116():9-15. PubMed ID: 24252442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline.
    Glennon RA; Misenheimer BR
    Pharmacol Biochem Behav; 1989 Aug; 33(4):909-12. PubMed ID: 2575759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Examining the role of oxytocin in the interoceptive effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') using a drug discrimination paradigm in the rat.
    Broadbear JH; Tunstall B; Beringer K
    Addict Biol; 2011 Apr; 16(2):202-14. PubMed ID: 21070509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atypical binding at dopamine and serotonin transporters contribute to the discriminative stimulus effects of mephedrone.
    DeLarge AF; Erwin LL; Winsauer PJ
    Neuropharmacology; 2017 Jun; 119():62-75. PubMed ID: 28396142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
    Marona-Lewicka D; Nichols DE
    Eur J Pharmacol; 1994 Jun; 258(1-2):1-13. PubMed ID: 7925587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psilocybin-induced stimulus control in the rat.
    Winter JC; Rice KC; Amorosi DJ; Rabin RA
    Pharmacol Biochem Behav; 2007 Oct; 87(4):472-80. PubMed ID: 17688928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats.
    Krebs KM; Geyer MA
    Psychopharmacology (Berl); 1993; 113(2):284-7. PubMed ID: 7855195
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discriminative stimulus effects of N,N-diisopropyltryptamine.
    Carbonaro TM; Forster MJ; Gatch MB
    Psychopharmacology (Berl); 2013 Mar; 226(2):241-6. PubMed ID: 23070023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3,4-N-methlenedioxymethamphetamine-induced hypophagia is maintained in 5-HT1B receptor knockout mice, but suppressed by the 5-HT2C receptor antagonist RS102221.
    Conductier G; Crosson C; Hen R; Bockaert J; Compan V
    Neuropsychopharmacology; 2005 Jun; 30(6):1056-63. PubMed ID: 15668722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats.
    Panos JJ; Baker LE
    Pharmacol Biochem Behav; 2012 Jan; 100(3):377-81. PubMed ID: 21978942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.
    Dolan SB; Forster MJ; Gatch MB
    Drug Alcohol Depend; 2017 Nov; 180():39-45. PubMed ID: 28865391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chlormethiazole potentiates the discriminative stimulus effects of methamphetamine in rats.
    Gasior M; Witkin JM; Goldberg SR; Munzar P
    Eur J Pharmacol; 2004 Jun; 494(2-3):183-9. PubMed ID: 15212973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MDMA-like behavioral effects of N-substituted piperazines in the mouse.
    Yarosh HL; Katz EB; Coop A; Fantegrossi WE
    Pharmacol Biochem Behav; 2007 Nov; 88(1):18-27. PubMed ID: 17651790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.